Quadrant Capital Group’s Pacific Biosciences PACB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $14.9K | Buy |
12,016
+10,344
| +619% | +$12.8K | ﹤0.01% | 1335 |
|
|
2025
Q1 | $1.97K | Sell |
1,672
-1,896
| -53% | -$2.24K | ﹤0.01% | 2516 |
|
|
2024
Q4 | $6.53K | Buy |
3,568
+3,096
| +656% | +$5.67K | ﹤0.01% | 2250 |
|
|
2024
Q3 | $803 | Sell |
472
-139
| -23% | -$236 | ﹤0.01% | 2621 |
|
|
2024
Q2 | $838 | Buy |
611
+82
| +16% | +$112 | ﹤0.01% | 2580 |
|
|
2024
Q1 | $1.98K | Buy |
+529
| New | +$1.98K | ﹤0.01% | 2513 |
|
|
2021
Q2 | – | Sell |
-20
| Closed | -$1K | – | 2516 |
|
|
2021
Q1 | $1K | Buy |
+20
| New | +$1K | ﹤0.01% | 2266 |
|
|
2018
Q1 | – | Sell |
-354
| Closed | – | – | 2198 |
|
|
2017
Q4 | $0 | Hold |
354
| – | – | ﹤0.01% | 2147 |
|
|
2017
Q3 | $1K | Hold |
354
| – | – | ﹤0.01% | 2000 |
|
|
2017
Q2 | $0 | Buy |
+354
| New | – | ﹤0.01% | 2003 |
|